Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (876)	2/23/1999 8:46:00 AM
From: Harold Engstrom	Respond to of 1686

JEB, I think few analysts are really capable of making upgrade or downgrade recommendations that are accurate. Biogen is a good case in point: there have been upgrades and downgrades over the past two years, but the company share price has just appreciated the whole while. The upgrades and downgrades didn't even occur at shortterm maxima and minima. I think brokerage analysis is interesting for the facts, but not for the opinion. The forcasting is not usually very good (with a couple of notable exceptions - e.g. May Kin Ho sp?). Better opinions can be had from V1, Peter Suzman, Rick, and others here. My own opinion, FWIW, is that if Avonex continues to gain market share and the market increases in general the way it has, the company will see strong earnings growth for the next two years. At that point, LFA3TIP, CVT124, 5C8 and VLA4 will begin to roll into the marketplace and earnings will accelerate to another order of magnitude.

To: JEB who wrote (876)	2/23/1999 9:59:00 AM
From: Beltropolis Boy	Read Replies (1) \| Respond to of 1686

>Yes, I agree but what about the upgrade. That's the confusing part. Would a company buy back shares before a split? I'm going to call PJ today and get them to clarify their target position. JEB. please do and let us know what you discover. my initial feeling when we joked about the potential split, was that the $90 target must be a typo. then again, bizarrely, it's reiterated today: news.com^2FGene~BGEN~BLO~389753170~~~~~,00.html fwiw, JP morgan's target is $112: news.com^2FGene~BGEN~BLO~378333560~~~~~,00.html -chris.